National Health Measures Survey 2022–24

The National Health Measures Survey (NHMS) 2022–24 was conducted from January 2022 to April 2024 and involved the collection of biomedical samples from participants aged 5 years and over across Australia, excluding very remote areas and discrete Aboriginal and Torres Strait Islander communities.

It measured specific biomarkers for chronic disease and nutrition status, from tests on blood and urine samples from volunteering participants selected in either the National Health Survey 2022 or the National Nutrition and Physical Activity Survey 2023.

Biomarkers collected include:

• chronic disease biomarkers, including tests for diabetes, cardiovascular disease, kidney disease and liver function
• nutrient biomarkers, including tests for iron, folate, vitamin B12, iodine, vitamin D, sodium and potassium levels.

In addition to chronic disease and nutrient biomarkers, the NHMS 2022–24 included tests for per- and polyfluoroalkyl substances, which are chemical contaminants found in the environment.

Participants’ self-reported information on health conditions and health risk factors, such as diet, physical activity and smoking, was taken from their responses in the other IHMHS surveys. For more information, see Overlap between surveys in the IHMHS.

This was the second time the ABS collected voluntary biomedical data in the NHMS. It was previously collected in 2011–13.

For main findings, see National Health Measures Survey, 2022–24.

For more information on the scope, geography, collection method, reporting guidelines used and history of changes, see National Health Measures Survey methodology, 2022–24.